CRYOPORT, INC. Finance Lease, Liability, Current
CRYOPORT, INC. (CYRX) had Finance Lease, Liability, Current of $448.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:FinanceLeaseLiabilityCurrent · last filed 2026-08-06
- 2026-06-30: Finance Lease, Liability, Current $448.00K.
- 2026-03-31: Finance Lease, Liability, Current $419.00K.
- 2025-12-31: Finance Lease, Liability, Current $422.00K.
- 2025-09-30: Finance Lease, Liability, Current $428.00K.
| Period end | Finance Lease, Liability, Current | Finance Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $448.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $419.00K 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $422.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $428.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $427.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $340.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $315.00K 10-K · filed 2026-03-05 | $488.00K 10-K · filed 2025-03-07 |
| 2024-09-30 | $470.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $365.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $301.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $286.00K 10-K · filed 2025-03-07 | |
| 2023-09-30 | $195.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $191.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $114.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $128.00K 10-K · filed 2024-03-13 | |
| 2022-09-30 | $96.00K 10-Q · filed 2022-11-04 | |
| 2021-12-31 | $61.00K 10-K · filed 2023-02-28 | |
| 2021-09-30 | $61.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $55.00K 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $60.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $59.00K 10-K · filed 2022-02-28 | |
| 2020-09-30 | $63.62K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $57.95K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $72.21K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $25.00K 10-K · filed 2021-03-01 | $24.62K 10-K · filed 2020-03-10 |
| 2019-09-30 | $24.25K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $25.94K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $23.53K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $23.19K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |